GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Medeze Group PCL (BKK:MEDEZE) » Definitions » Cash Flow from Financing

Medeze Group PCL (BKK:MEDEZE) Cash Flow from Financing : ฿-1.9 Mil (TTM As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Medeze Group PCL Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the six months ended in Mar. 2024, Medeze Group PCL paid ฿0.0 Mil more to buy back shares than it received from issuing new shares. It spent ฿1.6 Mil paying down its debt. It paid ฿0.0 Mil more to buy back preferred shares than it received from issuing preferred shares. It received ฿0.0 Mil from paying cash dividends to shareholders. It spent ฿0.2 Mil on other financial activities. In all, Medeze Group PCL spent ฿1.9 Mil on financial activities for the six months ended in Mar. 2024.


Medeze Group PCL Cash Flow from Financing Historical Data

The historical data trend for Medeze Group PCL's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medeze Group PCL Cash Flow from Financing Chart

Medeze Group PCL Annual Data
Trend Dec23 Dec24
Cash Flow from Financing
-101.59 2,001.98

Medeze Group PCL Semi-Annual Data
Mar23 Mar24
Cash Flow from Financing -1.59 -1.86

Medeze Group PCL Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Medeze Group PCL's Cash from Financing for the fiscal year that ended in Dec. 2024 is calculated as:

Medeze Group PCL's Cash from Financing for the quarter that ended in Mar. 2024 is:


For stock reported annually, GuruFocus uses latest annual data as the TTM data. Cash Flow from Financing for the trailing twelve months (TTM) ended in Mar. 2024 was ฿-1.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medeze Group PCL  (BKK:MEDEZE) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Medeze Group PCL's issuance of stock for the six months ended in Mar. 2024 was ฿0.0 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

Medeze Group PCL's repurchase of stock for the six months ended in Mar. 2024 was ฿0.0 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Medeze Group PCL's net issuance of debt for the six months ended in Mar. 2024 was ฿-1.6 Mil. Medeze Group PCL spent ฿1.6 Mil paying down its debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Medeze Group PCL's net issuance of preferred for the six months ended in Mar. 2024 was ฿0.0 Mil. Medeze Group PCL paid ฿0.0 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Medeze Group PCL's cash flow for dividends for the six months ended in Mar. 2024 was ฿0.0 Mil. Medeze Group PCL received ฿0.0 Mil from paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

Medeze Group PCL's other financing for the six months ended in Mar. 2024 was ฿-0.2 Mil. Medeze Group PCL spent ฿0.2 Mil on other financial activities.


Medeze Group PCL Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of Medeze Group PCL's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


Medeze Group PCL Business Description

Traded in Other Exchanges
N/A
Address
Phuttha Monthon Sai 4 Road, 28/9 Moo 8, Krathum Lom, Sam Phran, Nakhon Pathom, THA, 73220
Medeze Group PCL is engaged in the business of providing stem cell storage, analyzing, isolation, cultivation and preservation services for medical use. It is organised into four reportable segments: Stem cell sample collection service segment; White blood cell potential testing service segment; Other services segment and Sales of products segment.

Medeze Group PCL Headlines

No Headlines